a magnifying glass

adobe pdf icon Analogic Receives TSA Funding for DualUse Threat-Detection Systems

PEABODY, Mass., March 15, 2012 (GLOBE NEWSWIRE) — Analogic Corporation (Nasdaq:ALOG), enabling the world’s medical imaging and aviation security technology, today announced that it has received up to $2.6 million of funding from the U.S. Transportation Security Administration (TSA) for upgrade of COBRA DualUseTM threat detection systems. Built on Analogic’s proprietary 3-D computed tomography (CT) technology, the COBRA DualUse system screens both carry-on and checked baggage, improving airport efficiency and security.

Jim Green, Analogic’s president and CEO, commented, “The COBRA DualUse system advances CT threat-detection capabilities at the checkpoint, particularly at small and medium-sized airports. We value our partnership with TSA and look forward to the deployment of this innovative and cost effective technology.”

Analogic designed the COBRA DualUse system to improve operational efficiency and lower lifecycle costs while providing superior threat detection for both checkpoint and checked applications. System benefits include:

  1. Reduced Cost:  A single system with both checkpoint and checked baggage capabilities that lowers overall acquisition, deployment, and maintenance costs;
  2. Enhanced Security:  Checkpoint system that provides TSA-certified checked-baggage screening capability; and
  3. Increased Throughput:  Laptops can remain in bags; up to 30 percent increase compared to current checkpoint technologies.

Analogic’s CT technology meets the highest TSA standard for certified threat detection. Over the past fifteen years, Analogic has developed and deployed more than 1000 state-of-the-art threat-detection systems and subsystems for use in airports around the world. Analogic provides innovative solutions for a wide spectrum of customers ranging from small regional airports to large international hubs.

Forward-Looking Statements

Any statements about future expectations, plans, and prospects for the Company, including statements containing the words “believes,” “anticipates,” “plans,” “expects,” and similar expressions, constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including risks relating to product development and commercialization, limited demand for the Company’s products, risks associated with competition, uncertainties associated with regulatory agency approvals, competitive pricing pressures, downturns in the economy, the risk of potential intellectual property litigation, and other factors discussed in our most recent quarterly report filed with the Securities and Exchange Commission. In addition, the
forward-looking statements included in this presentation represent the Company’s views as of the date of this document. While the Company anticipates that subsequent events and developments will cause the Company’s views to change, the Company specifically disclaims any obligation to update these forward-looking statements. These forward-looking statements should not be relied upon as representing the Company’s views as of any later date.

About Analogic

Analogic (Nasdaq:ALOG) provides leading-edge healthcare and security technology solutions to advance the practice of medicine and save lives. We are recognized around the world for advanced imaging systems and technology that enable computed tomography, ultrasound, digital mammography, and magnetic resonance imaging (MRI), as well as automated threat detection for aviation security. Our CT, MRI, digital mammography, and ultrasound transducer products are sold to original equipment manufacturers (OEMs), providing state-of-the-art capability and enabling them to enter new markets and expand their existing market presence. Our market-leading BK Medical branded ultrasound systems, used in procedure-driven markets such as urology, surgery, and anesthesia, are sold to clinical end users through our direct sales force. For over 40 years we’ve enabled customers to thrive, improving the health
and enhancing the safety of people around the world. Analogic is headquartered just north of Boston, Massachusetts. For more information, visit www.analogic.com.

Analogic is a registered trademark of Analogic Corporation.

The globe logo and COBRA DualUse are trademarks of Analogic Corporation.

CONTACT: Investor Contact:

         Mark Namaroff

         Director of Investor Relations

         & Corporate Marketing

         (978) 326-4058

         investorrelations@analogic.com